prices

FAS opened a case against “Novartis Pharma” Ltd.
The company is suspected of fixing monopolistically high price for “Tyverb” medicinal drug
more
FAS exposed excessive prices for preventive-and-immune drug
The third stage of comparative analysis of drug prices exposed pricing violations for 7 medicines in Russia
more
FAS managed to decrease 239 prices on the drugs for treating HIV, tuberculosis, hepatitis B and C
The minimum saving of budgetary funds from reducing prices will reach over 63 million RUB for the Ministry of health Care for HIV-treatment drugs
more
FAS issued an injunction to four stevedores to transfer nearly 17 billion RUB to the federal budget for abusing dominance
The FAS Russia issued injunctions to “Novorossiysk Commercial Seaport” PJSC (“NCSP” PJSC), “First Container Terminal” JSC (“FCT” JSC), “Petrolesport” JSC and “Vostochnaya Stevedoring Company” Ltd. (“VSC” Ltd.) to eliminate antimonopoly violations and transfer the income gained as a result of abusing dominance to the federal budget.
more